| Efficient RNA drug delivery using red blood cell extracellular vesicles WM Usman, TC Pham, YY Kwok, LT Vu, V Ma, B Peng, YS Chan, L Wei, ... Nature communications 9 (1), 2359, 2018 | 478 | 2018 |
| Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b LT Vu, B Peng, DX Zhang, V Ma, CA Mathey-Andrews, CK Lam, ... Journal of extracellular vesicles 8 (1), 1599680, 2019 | 118 | 2019 |
| Annexin A5 as a potential marker in tumors B Peng, C Guo, H Guan, S Liu, MZ Sun Clinica Chimica Acta 427, 42-48, 2014 | 114 | 2014 |
| Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery TC Pham, MK Jayasinghe, TT Pham, Y Yang, L Wei, WM Usman, H Chen, ... Journal of extracellular vesicles 10 (4), e12057, 2021 | 109 | 2021 |
| Essential functions of miR‐125b in cancer B Peng, PY Theng, MTN Le Cell proliferation 54 (2), e12913, 2021 | 51 | 2021 |
| Structural analysis reveals the formation and role of RNA G-quadruplex structures in human mature microRNAs KL Chan, B Peng, MI Umar, CY Chan, AB Sahakyan, MTN Le, CK Kwok Chemical communications 54 (77), 10878-10881, 2018 | 45 | 2018 |
| Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy B Peng, TM Nguyen, MK Jayasinghe, C Gao, TT Pham, LT Vu, EYM Yeo, ... Journal of Extracellular Vesicles 11 (4), e12187, 2022 | 36 | 2022 |
| New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies MK Jayasinghe, M Tan, B Peng, Y Yang, G Sethi, M Pirisinu, MTN Le Seminars in Cancer Biology 74, 62-78, 2021 | 33 | 2021 |
| Advances in drug delivery systems based on red blood cells and their membrane-derived nanoparticles PHD Nguyen, MK Jayasinghe, AH Le, B Peng, MTN Le ACS nano 17 (6), 5187-5210, 2023 | 32 | 2023 |
| Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy MK Jayasinghe, M Pirisinu, Y Yang, B Peng, TT Pham, CY Lee, M Tan, ... Theranostics 12 (7), 3288, 2022 | 25 | 2022 |
| Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer B Liu, XP Huang, YL Hu, TT Chen, BY Peng, NN Gao, ZC Jin, TL Jia, ... Oncotarget 7 (36), 58038, 2016 | 23 | 2016 |
| Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation Y Diao, X Wang, Y Wan, J Zhong, D Gao, Y Liu, N Gao, W Li, B Liu, ... Oncology reports 35 (2), 793-800, 2016 | 18 | 2016 |
| ANXA5 level is linked to in vitro and in vivo tumor malignancy and lymphatic metastasis of murine hepatocarcinoma cell B Peng, S Liu, C Guo, X Sun, MZ Sun Future Oncology 12 (1), 31-42, 2016 | 15 | 2016 |
| Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer DJT Tay, Y Song, B Peng, TB Toh, L Hooi, DFK Toh, HQ Hong, SJ Tang, ... Molecular therapy 29 (11), 3258-3273, 2021 | 13 | 2021 |
| Red blood cell extracellular vesicles deliver therapeutic siRNAs to skeletal muscles for treatment of cancer cachexia B Peng, Y Yang, Z Wu, R Tan, TT Pham, EYM Yeo, M Pirisinu, ... Molecular Therapy 31 (5), 1418-1436, 2023 | 5 | 2023 |
| Harnessing Extracellular Vesicles from Red Blood Cells for Targeted Delivery of Therapeutic Peptides and RNAs for Leukemia Treatment MK Jayasinghe, M Pirisinu, H Chen, Y Yang, B Peng, J Shi, MTN Le Blood 138 (Supplement 1), 3980-3980, 2021 | 3 | 2021 |
| Endocytosis of red blood cell extracellular vesicles by macrophages leads to cytoplasmic heme release and prevents foam cell formation in atherosclerosis TT Pham, AH Le, CP Dang, SY Chong, DV Do, B Peng, MK Jayasinghe, ... Journal of Extracellular Vesicles 12 (8), 12354, 2023 | 2 | 2023 |
| Abstract LT08: Extracellular Vesicle Surface Display Enhances the Therapeutic Efficacy and Safety Profile of Cancer Immunotherapy MK Jayasinghe, DLX Tian, YS Lay, CY Lee, BZJ Yeo, D Van Hoang, ... Cancer Research 84 (8_Supplement), LT08-LT08, 2024 | | 2024 |
| Surface Modified Red Blood Cells And Methods Of Generating The Same TNM Le, MK Jayasinghe, P Boya, J Shi US Patent App. 18/274,649, 2024 | | 2024 |
| Activation of S1P2 is protective against cisplatin‐induced peripheral neuropathy BWS Lam, P Xiang, B Peng, LJJ Soon, ATY Yam, CMH Lim, Y Zheng, ... Cell Proliferation 57 (2), 2024 | | 2024 |
